Distribution of Dopamine Receptor 2 DRD2 rs1800497 Polymorphisms in Professional Football Players

Year 2021, Volume: 23 Issue: 2, 185 - 189, 31.08.2021

Beste Tacal Aslan , Özlem Özge Yılmaz , Tolga Polat , Çisem Şılar , Başak Funda Eken , Canan Sercan Doğan , Korkut Ulucan

https://izlik.org/JA76FD75CM

Abstract

According to the literature, the genetic makeup of athletes contributes to their athletic performance. Athletic performance depends on genetic and environmental factors relating to the athlete. The study of sports genetics includes extensive research into identifying genes that affect athletic performance. Psychological factors affect athletic performance and so dopamine contributes to the determination of that performance. One of the neurotransmitters of the dopaminergic system is dopamine, which affects the athlete mentally and psychologically. The dopamine receptor D2 (DRD2) rs1800497 polymorphism affects the brain’s dopaminergic system and athletic performance. This study aimed to determine the genotype and allele distributions of the DRD2 rs180047 polymorphism in football players and compare them with the control group. For this purpose, 21 football players were enrolled in our study. Genotyping was performed by PCR after DNAs were isolated from buccal epithelial cells. When we examined the genotype distributions, the AG and GG were found as 5 (24%) and 16 (76%), respectively. No AA genotype was found for DRD2. When allelic distributions were examined in the athlete group, the A allele was counted as 5 (12%) and the G allele as 37 (88%). In our study cohort, the DRD2 rs1800497 polymorphism was found to be dominated by the GG genotype and the G allele. We believe that the DRD2 A allele is associated with addiction and thus with athletic performance. However, more studies with athletes from different branches are needed to reveal the effect of DRD2 rs1800497 polymorphism on athletic performance.

Keywords

sports , genetics , polymorphism , DRD2 , football

References

• 1. Corak A, Kapıcı S, Sercan C, Akkoç O, Ulucan K. A pilot study for determination of anxiety related SLC6A4 promoter “S” and “L” alleles in healthy Turkish athletes. Cell Mol Biol (Noisy-le-grand). 2017; 63(5): 29-31. doi: 10.14715/cmb/2017.63.5.6
• 2. Ulucan K. Literature review of Turkish sportsmen in terms of ACTN3 R577X polymorphism. Clin Exp Health Sci. 2016; 6: 44–47. doi: 10.5152/clinexphealthsci.2016.059
• 3. Polat T, Dogan CS, Dogan M, Akçay T, Ulucan K. Distribution of α ‑ actinin ‑ 3 rs1815739 and angiotensin ‑ 1 converting enzyme InDel polymorphisms in Turkish bodybuilders. Biomedical Reports. 2020; 13(6): 1–5. doi: 10.3892/br.2020.1374
• 4. Eken BF, Akpınaroğlu C, Arslan KS, Sercan C, Ulucan K. Effects of genes to psychological factors in sports. J Neurobehav Sci. 2018; 5(1): 56–61. doi: 10.5455/JNBS.1516796381
• 5. Hornykiewicz O. The action of dopamine on the arterial pressure of the guinea pig. Br J Pharmacol. 1958; 13: 91- 94. doi: 10.1111/j.1476-5381.1958.tb00197.x
• 6. Foley TE, Fleshner EM. Neuroplasticity of Dopamine Circuits After Exercise : Implications for Central Fatigue. Neuromolecular Med. 2008; 10: 67–80. doi: 10.1007/s12017-008-8032-3
• 7. Jaber M, Robinson SW, Missale C, Caron MG. Dopamine receptors and brain function. Neuropharmacology. 1996; 35: 1503–1519. doi: 10.1016/s0028-3908(96)00100-1
• 8. Melis M, Greco B, Tonini R. Interplay between synaptic endocannabinoid signaling and metaplasticity in neuronal circuit function and dysfunction. European Journal of Neuroscience. 2014; 9: 1189–1201. doi: 10.1111/ejn.12501
• 9. Berridge KC. Is Addiction a Brain Disease? Neuroethics. 2017; 10(1): 29–33. doi: 10.1007/s12152-016-9286-3
• 10. Thompson J, Thomas N, Singleton A, Piggott ML, loyd S, Perry EK, Morris CM, Perry RH, Ferrier IN, Court JA. D2 dopamine receptor gene (DRD2) taq1 A polymorphism reduced dopamine D2 receptor bindingin the human striatum associated with A1 allele. Pharmacogenetics. 1997; 7: 479-84. doi: 10.1097/00008571-199712000-00006
• 11. Gingrich JA, Caron MG. Recent advances in the molecular biology of dopamine receptors. Annu Rev Neurosci. 1993; 16: 299-321. doi: 10.1146/annurev.ne.16.030193.001503
• 12. Drago J, Padungchaichot P, Accili D, Fuchs S. Dopamine receptors and dopamine transporter in brain function and addictive behaviors: insights from targeted mouse mutants. Dev Neurosci. 1998; 20: 188–203. doi: 10.1159/000017313
• 13. Turner E, Ewing J, Shilling P, Smith TL, Irwin M, Schuckit M, Kelsoe JR. Lack of association between an RFLP near the D2 dopamine receptor gene and severe alcoholism. Biol Psychiatry. 1992; 31(3): 285-290. doi: 10.1016/0006-3223(92)90052-2
• 14. Pohjalainen T, Rinne JO, Någren K, Lehikoinen P, Anttila K, Syvälahti EKG, Hietala J. The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. Mol Psychiatry. 1998; 3: 256–260. doi: 10.1038/sj.mp.4000350
• 15. World Medical Association. World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. JAMA. 2013; 310(20): 2191–2194. doi: 10.1001/jama.2013.281053
• 16. Noble EP. Addiction and its reward process through polymorphisms of the D2 dopamine receptor gene: a review. European Psychiatry. 2000; 15: 79– 89. doi: 10.1016/s0924-9338(00)00208-x
• 17. Ndamanisha JC, Guo L. Nonenzymatic glucose detection at ordered mesoporous carbon modified electrode. Biosens Bioelectron. 2009; 23: 60- 63. doi: 10.1016/j.bioelechem.2009.05.003
• 18. Munafo MR, Matheson IJ, Flint J. Association of the DRD2 gene Taq1A polymorphism and alcoholism: a meta-analysis of case-control studies and evidence of publication bias. Mol Psychiatry. 2007; 12: 454-461. doi: 10.1038/sj.mp.4001938
• 19. Grandy DK, Litt M, Allen L, Bunzow JR, Marchionni M, Makam H, Reed L, Magenis RE, Civelli O. The human dopamine D2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP. Am. J. Hum. Genet. 1989; 45(5): 778-785. PMCID: PMC1683432
• 20. Yüksel İ, Kapıcı S, Sercan C, Kulaksız H, Polat T, Turan G, Ulucan K. Addiction Related DRD2 gene rs 1800497 polymorphism distribution in volleyball players and bodybuilders. J Neurobehav Sci. 2017; 4(3): 122-125. doi: 10.5455/JNBS.1502377893
• 21. Özcan ÖÖ, Sercan C, Kulaksız H, Karahan M, Ulucan K. The Effect of Dopamin D2 Receptor TAQ A1 Allele on Sprinter and Endurance Athlete. International Journal of Medical. Medicine and Health Science. 2018; 12(9): 353-356. doi: 10.5281/zenodo.1474429
• 22. Abe D, Doi H, Asai T, Kimura M, Wada T, Takahashi Y, Matsumoto T, Shinohara K. Association between COMT Val158Met polymorphism and competition results of competitive swimmers. J. Sports Sci. 2017; 36(4): 393-397. doi: 10.1080/02640414.2017.1309058